ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: An update on guidance during the post-lockdown phase and selected results from a membership survey.

Publication Year: 2020

DOI:
10.1055/a-1213-5761

PMCID:
PMC7520543

PMID:
32643767

Journal Information

Full Title: Endoscopy

Abbreviation: Endoscopy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests I.M. Gralnek has received lecture fees from AstraZeneca, Taro Pharma, Vifor Pharma, and 3D Matrix (ongoing), and consultancy fees from Boston Scientific, GI View, Motus GI, and Symbionix (ongoing); he is a member of the Medical Advisory Board of Motus GI. J.E. van Hooft has received lecture fees from Medtronics (2014–2015) and Cook Medical (2019), and consultancy fees from Boston Scientific (2014–2017); her department has received research grants from Cook Medical (2014–2019) and Abbott (2014–2017). M. Kaminski has received lecture fees from Boston Scientific (2018– ongoing) and consultancy fees from Olympus and Fujifilm (2018– ongoing). P.D. Siersema has received research grants from Norgine, Pentax, Microtech, Yakult, and Motus GI (ongoing); he is a member of the Medical Advisory Board of Motus GI. G. Antonelli, M. Arvanitakis, P. Bhandari, R. Bisschops, M. Dinis-Ribeiro, A. Ebigbo, C. Hassan, H. Messmann, M. Pellisé, H. Pohl, T. Ponchon, K. Triantafyllou, A. M. Voiosu, and G. Webster, have no competing interests."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025